Benchmark Maintains Speculative Buy on Cardio Diagnostics Hldgs, Raises Price Target to $2
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson maintains a Speculative Buy rating on Cardio Diagnostics Hldgs (NASDAQ:CDIO) and raises the price target from $1.35 to $2.
June 06, 2024 | 2:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Benchmark analyst Bruce Jackson maintains a Speculative Buy rating on Cardio Diagnostics Hldgs and raises the price target from $1.35 to $2.
The raised price target from $1.35 to $2 and the maintained Speculative Buy rating by a reputable analyst is likely to positively impact investor sentiment and drive short-term price appreciation for CDIO.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100